论文部分内容阅读
目的对重症肌无力(MG)患者临床特点和治疗效果进行分析。方法对50例MG患者的临床治疗,对2015年5月至2016年12月在本院进行治疗的成人型重症肌无力50例进行研究。其中男25例,女25例;年龄20-79岁,平均51岁;临床表现按临床分型不同出现不同症状进行回顾性分析。结果 50例患者均采用药物治疗,总有效率达97.1%。结论 MG治疗主要采用抗胆碱酯酶药、免疫调节剂、胸腺摘除等方法。针对患者个体的治疗应考虑患者的年龄、严重程度、合并症的存在等等。通常最先应用胆碱酯酶抑制剂控制症状,直至确定其不能完全控制症状或完全控制症状所需的剂量难以耐受。应根据患者情况合理选择。
Objective To analyze the clinical features and therapeutic effects of myasthenia gravis (MG). Methods The clinical treatment of 50 cases of MG patients, from May 2015 to December 2016 in our hospital for treatment of 50 cases of adult myasthenia gravis. Including 25 males and 25 females; aged 20-79 years, mean 51 years; clinical manifestations according to different clinical manifestations of different symptoms were retrospectively analyzed. Results 50 patients were treated with drugs, the total effective rate was 97.1%. Conclusion MG treatment mainly uses anticholinesterase drugs, immunomodulators, thymus removal and other methods. Treatment for individual patients should consider the patient’s age, severity, the presence of comorbidities and so on. Cholinesterase inhibitors are usually the first to be used to control symptoms until it is difficult to tolerate doses that are determined to not fully control the symptoms or to completely control the symptoms. Should be based on the patient’s condition a reasonable choice.